What does intangible asset and IP valuation for UK and European investors in the UAE cover? It is an independent fair value estimate of brands, patents, technology and customer relationships, prepared to IVS and IFRS 3. It supports buy-and-build purchase price allocation, earn-out pricing and fund reporting. Corvian Advisory provides it from Dubai as UAE-based valuation advice for UK and European investors and UK and European-linked transactions, through a CFA-led team with 15+ years of Big 4 experience. Fixed fee from GBP 3,000, typically 3–6 weeks.
Independent, IVS-aligned and IFRS 3-compliant valuation of intangible assets for UK and European groups, funds and founders with UAE operations. The emphasis is on brand, distribution rights and technology in buy-and-build platforms, and every report is signed by CFA, CA and ACCA qualified practitioners.
A CFA Charterholder and Chartered Accountant with Big 4 experience leads each engagement. IFRS 3 is native to European reporting, so PPA reports slot directly into group accounts and audit files.
European-linked mandates often involve several bolt-ons in sequence, so we keep methods and useful-life conventions consistent from one acquisition to the next.
Corvian Advisory provides UAE-based valuation advice to UK and European investors and on UK and European-linked transactions, prepared to IVS and IFRS 3. We are not registered valuers in the UK and Europe. Where a statutory or regulatory valuation specific to the UK and Europe is required, we work alongside a locally authorised valuer and coordinate our analysis with theirs.
For UK and European-linked platforms we align each acquisition's valuation approach so intangible values are comparable across the group.
Royalties avoided by owning a brand or technology, benchmarked against European and international licence data and tested against margin capacity.
Attributes cash flow to customer relationships and technology after charges for other assets, with attrition curves derived from actual customer data.
Cost to recreate software, databases and processes, adjusted for obsolescence and used as a floor value.
Precedent transactions and multiples for distribution, brand and technology assets used to cross-check income-based results.
Royalty-relief valuation with a consistent rate framework across acquisitions.
Contract-based valuation considering tenor, exclusivity and renewal risk.
Attrition-based excess earnings, calibrated to observed churn.
Cost and income methods with remaining life assessment.
Value of committed contracts at acquisition date.
Intangible inputs to equity valuation of option and share plans.
UK and European-linked mandates are typically in services, technology, healthcare and consumer sectors.
| Sector | Primary Approach | Key Value Driver |
|---|---|---|
| Business Services | MPEEM | Contract length, churn |
| Software & Technology | MPEEM, cost | Renewals, technology life |
| Healthcare Services | MPEEM, relief-from-royalty | Referral sources, brand |
| Consumer & Hospitality | Relief-from-royalty | Brand strength, licensing |
| Industrial Distribution | MPEEM | Agency terms, exclusivity |
| Education & Training | MPEEM | Enrolment, brand |
Every engagement starts with a fixed-scope proposal agreed and signed before work begins. Fees are quoted in GBP, EUR or USD, with no hourly billing.
One intangible class, one primary method, with rate benchmarking.
All identifiable intangibles at fair value, with IFRS 3 documentation and audit-ready workpapers.
Analysis of IP held or licensed between related entities, benchmarked to OECD-aligned principles.
A call on the transaction, the platform history and the useful-life conventions already used. Fixed fee agreed upfront.
Identify recognisable intangibles and collect contracts, customer data, agency agreements and technology documentation.
Method selection per asset, royalty and attrition analysis, useful-life assessment and consistency check with prior acquisitions.
A walkthrough of the draft valuation with your finance team and auditors before finalising.
Signed report with methodology, assumptions, useful-life analysis and sensitivities, prepared to IVS and consistent with IFRS 13 and IFRS 3.
Answers to what UK and European groups ask before commissioning an IP valuation.
Send us the outline and we will confirm a fixed fee within one business day.